Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
---|
11/01/1983 | US4412985 Depyrogenation process |
11/01/1983 | US4412946 Immunostimulating glycoproteins |
10/27/1983 | WO1983003679A1 Antibodies having dual specificities, their preparation and uses therefor |
10/27/1983 | WO1983003623A1 CODING DNA FRAGMENTS FOR POLYPEPTIDES CONTAINING AT LEAST ONE ANTIGENIC DETERMINANT OF THE PAPILLOMAVIRUS PARTICULARLY OF THE 1a HPV TYPE AND CORRESPONDING POLYPEPTIDES |
10/27/1983 | WO1983003547A1 Synthetic picornavirus antigen |
10/27/1983 | WO1983003546A1 Temperature sensitive reassortant viruses and a vaccine against equine influenza |
10/26/1983 | EP0092456A1 DNA fragments encoding for polypeptides containing at least an antigenic determinant of Papilloma viruses, notably of the HPV 1A-type, and corresponding polypeptides |
10/26/1983 | EP0092249A2 Non-A, non-B hepatitis-associated monoclonal antibody and diagnostic reagent |
10/26/1983 | EP0092223A2 Cytosole-CEA-measurement as predictative test in carcinoma, particularly mammacarcinoma |
10/26/1983 | EP0092186A2 Method of preparing gamma globulin suitable for intravenous administration |
10/26/1983 | EP0091958A1 Liposome conjugates and diagnostic methods therewith |
10/25/1983 | US4411993 Antitumor and -carcinogenic agents |
10/25/1983 | US4411888 Composition of a novel immunogen for protection against diarrheal disease caused by enterotoxigenic Escherichia coli |
10/25/1983 | CA1155764A2 Detection of non-a, non-b hepatitis associated antigen |
10/25/1983 | CA1155763A1 Vaccine for preventing persistent feline leukemia viremia in cats |
10/19/1983 | EP0091543A1 Anti-interferon antibodies and method of producing same |
10/18/1983 | US4410660 Binding assay for the detection of mycobacteria |
10/18/1983 | US4410510 Method for preparing a purified extraction residue fraction and its use in stimulating the immune response |
10/18/1983 | CA1155393A1 Brucellosis vaccine for cattle containing mycolate esters of trehalose |
10/13/1983 | WO1983003477A1 Blood cell grouping reagent |
10/13/1983 | WO1983003426A1 Magnetic carbohydrate particles as carriers for affinity separation purposes, e.g. cell separation |
10/13/1983 | WO1983003354A1 Neisseria gonorrhoeae vaccine |
10/12/1983 | EP0090966A1 Process for antigen determination |
10/12/1983 | EP0090892A1 Process for the purification of physiologically active substance having antitumour activity |
10/12/1983 | EP0090886A2 Stabilization of influenza virus vaccine |
10/11/1983 | US4409105 Dried, sterilized, gamma-globulin-fixed column and a process for preparing the same |
10/11/1983 | CA1155057A1 Vaccine and method of making |
10/11/1983 | CA1155056A1 Vaccine for the prevention and treatment of bovine mastitis |
10/11/1983 | CA1155055A1 Modified living canine parvovirus vaccine |
10/05/1983 | EP0090732A1 Proteic product, its obtention and use as a medicament, in particular an immuno regulator and anti-allergic agent |
10/05/1983 | EP0090660A2 Neisseria gonorrhoeae vaccine |
10/05/1983 | EP0090581A2 Small peptides with the specificity of foot and mouth disease viral antigens |
10/05/1983 | EP0090359A2 Method for the determination of an allergy and method for the specific determination of the allergen responsible for the allergy |
10/05/1983 | EP0090343A2 Hybrid cell, process for preparaing it and its use |
10/04/1983 | US4407965 Process for preparing antibody |
10/04/1983 | US4407949 High molecular weight polysaccharide from hemophilus |
10/04/1983 | US4407796 Immunology |
10/04/1983 | CA1154673A1 Injectable rabies vaccine composition and method for preparing same |
10/04/1983 | CA1154670A1 Process for testing for the inactivation of vaccines, the harmlessness of blood products and the effectiveness of chemotherapeutic agents and disinfectants against viral hepatitis |
09/29/1983 | WO1983003307A1 Method for production of antiserum against granula fraction from endocrinologically active cells |
09/29/1983 | WO1983003306A1 Method and composition for free ligand assays |
09/29/1983 | WO1983003200A1 Cytotoxic medicines including at least an immunotoxine and an amine |
09/29/1983 | WO1983003199A1 Method for obtaining reduced infectivity variants from protozoan parasites, thus obtained variants and utilization thereof |
09/28/1983 | EP0089880A1 Covalent conjugates of an enzyme and an antibody, and medicinal compositions containing these conjugates |
09/28/1983 | EP0089854A2 Vaccine against DNA viruses |
09/28/1983 | EP0089598A1 Anti-streptolysin O-latex reagent and process for its production |
09/27/1983 | US4406890 Immunology; potentiation; stimulants |
09/27/1983 | US4406885 Preparation of native oncornavirus envelope subunits and vaccines therefrom |
09/27/1983 | CA1154438A1 Protein pp in15 xx, a process for its preparation and its use |
09/27/1983 | CA1154437A1 Protein, pp in11 xx, a process for its preparation and its use |
09/27/1983 | CA1154382A1 Vaccine and method of making |
09/21/1983 | EP0089290A1 Conjugates of haptenes and muramyl peptides having an immunogenic activity, and compositions containing them |
09/21/1983 | EP0089283A2 Bacterial toxoids, gram-negative immune globulin therefrom and their preparation |
09/21/1983 | EP0089270A1 Cytotoxic medicines containing at least one immune toxine and one amine |
09/21/1983 | EP0089008A2 Highly specific antiserum against Procollagen-peptide Col 1 (Type III),and Procollagen-peptide (Type III), its preparation and use thereof. |
09/21/1983 | EP0088994A2 Hybrid DNA, binding composition prepared thereby and processes therefor |
09/15/1983 | WO1983003055A1 Cytotixic drug formed by the association of at least one immunotoxine and chloroquine |
09/14/1983 | EP0088695A2 Antibody conjugates |
09/14/1983 | EP0088694A1 Cytotoxic medicine containing at least one immune toxine and chloroquine |
09/14/1983 | EP0088606A2 Monoclonal antibodies against lens epithelial cells |
09/14/1983 | EP0088303A2 Process for the preparation of polysaccharide-protein complexes from bacterial envelopes, products obtained and immunogenic compostions containing them |
09/14/1983 | EP0088302A2 Detoxified neurotoxine of E coli, process to prepare it and immunological compositions containing it |
09/13/1983 | US4404186 Immunizing poultry and mammals against gramnegative bacteria; animal husbandry |
09/13/1983 | CA1153696A1 Extract from plant of genus epimedium sp., process for preparation of said extract, immunostimulating agent comprising said extract as effective component and immunotherapy by using said extract |
09/07/1983 | EP0087735A2 Recombinant DNA, microorganism transformed therewith and their use |
09/07/1983 | EP0087728A1 Immunological latex-agglutination process |
09/06/1983 | US4402939 Vaccinating glycopeptidic antigenic fraction with a very high level of immunogenicity, isolated from cultures of pathogenic germs, processes for isolating said fraction and vaccines containing said fraction |
09/06/1983 | US4402872 Protein and process for isolating it |
09/06/1983 | CA1153310A1 Antigenic composition derived from bacteriodes nodosus |
09/06/1983 | CA1153309A1 Vaccines |
09/06/1983 | CA1153308A1 Preparation of enriched whole virus radioligand |
09/01/1983 | WO1983003008A1 METHOD FOR THE IDENTIFICATION AND PURIFICATION OF HUMAN LUNG TUMOR-ASSOCIATED ANTIGENS (hLTAA) AND CLINICAL DETECTION AND DETERMINATION OF THESE ANTIGENS |
09/01/1983 | WO1983002897A1 Materials and methods for herpes simplex virus vaccination |
09/01/1983 | WO1983002896A1 Method for the purification of parasite antigenic factors |
09/01/1983 | WO1983002895A1 Attenuation of vaccines with monoclonal antibody |
08/30/1983 | US4401658 Vaccine adjuvants, immunostimulants |
08/30/1983 | CA1152895A1 Process for the preparation of novel influenza virus strains and influenza virus vaccines containing them |
08/24/1983 | EP0086707A1 DNA fragments encoding for an immunogenic peptide capable of inducing in vivo synthesis of anti-polio virus antibodies |
08/24/1983 | EP0086548A2 A method of cleaving double stranded DNA |
08/23/1983 | US4400472 Novel rabies virus strain and a process for its preparation |
08/23/1983 | US4400376 Immunological preparations |
08/23/1983 | US4400316 C-Terminal fragment of human chorionic gonadotropin |
08/23/1983 | CA1152493A1 Thiolated polypeptide compound derived from a tetanus toxin fragment, the process for obtaining and its applications |
08/23/1983 | CA1152492A1 Reagents for use in binding assays to determine valproic acid |
08/23/1983 | CA1152491A1 Flavin adenine dinucleotide-labeled protein and polypeptide conjugates |
08/23/1983 | CA1152490A1 Beta-galactosyl-umbelliferone-labeled protein and polypeptide conjugates |
08/23/1983 | CA1152431A1 Composition and method for cancer detection in humans |
08/18/1983 | WO1983002725A1 Drugs comprising as association at least one immunotoxin and at least one monovalent carboxylic ionophora |
08/18/1983 | WO1983002456A3 New plasmids and bacterial strains and production process thereof |
08/17/1983 | EP0086152A1 Medicines containing an association of at least one immunotoxine and at least one monovalent carboxylic ionophore |
08/17/1983 | EP0086071A1 Ozone inactivated organisms as vaccines |
08/17/1983 | EP0086025A1 Infectious bronchitis vaccines |
08/17/1983 | EP0085747A2 Intravenously administrable human immunoglobuline and process for its preparation |
08/17/1983 | EP0085693A1 Subjects relating to human inteferon-alpha subtype proteins and corresponding antibodies |
08/16/1983 | US4398382 Method for washing and coating as well as for dosage of EIA-rings and a device for carrying out the method |
08/16/1983 | CA1152014A1 Lactate dehydrogenase mutants of streptococcus mutans |
08/16/1983 | CA1152001A1 Method for producing pertussis toxoid |
08/16/1983 | CA1152000A1 Immunization against dental caries with glucosyltransferase antigens |
08/10/1983 | EP0085469A1 Method of preparing an immunogen of Pasteurella multocida |
08/10/1983 | EP0085362A2 Method for determining allergic sensitivity |